IGF-1 deficiency in combination with a low basic hBD-2 and hBD-3 gene expression might counteract malignant transformation in pleomorphic adenomas in vitro

Cancer Invest. 2012 Feb;30(2):106-13. doi: 10.3109/07357907.2011.640651.

Abstract

This study investigated the IGF-1-influence on oncological relevant genes in pleomorphic adenomas. Therefore A64-tumor cells were stimulated by recombinant IGF-1. After RNA-extraction, transcript levels of hBD-1, hBD-2, hBD-3, DEFA1/3, DEFA4, S100A4, Psoriasin, DOC-1, EGF, EGFR, and IGFR were analyzed by qRT-PCR at t = 0, 4, 8, 24, 48, and 72 hr. The gene-products were visualized by immunostaining. A64-tumor-cells were deficient for hBD-1 and IGF-1. IGF-1 downregulates hBD-2 and hBD-3 without influencing hBD-1-expression. IGF-1 only slightly affects DEFA1/3-, DEFA4-, S100A4-, Psoriasin-, DOC-1-, EGF-, EGFR-, and IGFR-gene-expression. IGF-1-deficiency combined with low basic hBD-2-gene-expression and hBD-3-gene-expression might counteract, whereas hBD-1-deficiency promotes malignant transformation in pleomorphic adenomas.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma, Pleomorphic / genetics*
  • Adenoma, Pleomorphic / metabolism
  • Cell Growth Processes / physiology
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic / genetics*
  • Cell Transformation, Neoplastic / metabolism
  • Gene Expression
  • Humans
  • Immunohistochemistry
  • Insulin-Like Growth Factor I / deficiency*
  • Insulin-Like Growth Factor I / genetics
  • Insulin-Like Growth Factor I / metabolism
  • Insulin-Like Growth Factor I / pharmacology
  • Male
  • Middle Aged
  • Recombinant Proteins / pharmacology
  • Salivary Gland Neoplasms / genetics*
  • Salivary Gland Neoplasms / metabolism
  • beta-Defensins / biosynthesis
  • beta-Defensins / genetics*
  • beta-Defensins / metabolism

Substances

  • Recombinant Proteins
  • beta-Defensins
  • Insulin-Like Growth Factor I